Clinical Trial Update: A Phase 3 Study of Fluvoxamine (SME3110) in Pediatric/Adolescent Patients With Obsessive Compulsive Disorder [Phase 3]

View source ↗

Summary

This publication reports the completion and posting of results from a Phase 3 trial evaluating fluvoxamine for obsessive-compulsive disorder in pediatric and ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Luvox (Fluvoxamine)

Snippet

Sponsor: AbbVie | Conditions: Obsessive Compulsive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2017-12-04